Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective Study of Clinical Effectiveness of Remdesivir in Moderate to Severe and Critical Covid-19 Infections
TCTR20211109004Completed
- Sponsor
- N/A
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remdesivir in coronavirus disease 2019 (COVID-19), sponsored by N/A. Started Apr 2021; status: completed.
02
Drugs
remdesivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211109004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211109004.